Biosensors Industry

According to a research report "Biosensors Market by Type (Sensor Patch, Embedded Device), Product (Wearable, Non-Wearable), Wearable (Wristwear, Bodywear), Technology (Electrochemical, Optical, Piezoelectric, Thermal, Nanomechanical), Application and Region - Global Forecast to 2030" The global biosensors market is projected to grow from USD 34.51 billion in 2025 to USD 54.37 billion by 2030, at a CAGR of 9.5% Biosensors are semiconductor devices designed to detect biological responses and use transducers to convert these responses into electrical signals. They do this by combining a biological recognition element (bioreceptor) with a physicochemical transducer. High-growth opportunities in the food industry, environmental monitoring applications, and the wearable device market are driving the biosensors market.

Browse 198 market data Tables and 57 Figures spread through 227 Pages and in-depth TOC on "Biosensors Market"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/biosensors-market-798.html

Wearable biosensors will witness the highest CAGR during the forecast period.

Wearable biosensors typically combine wearable electronics and biosensors. They are a recent advancement in healthcare technology, enabling monitoring of vital signs in patients, athletes, the elderly, children, including premature infants, and individuals needing long-term care. Additionally, these devices provide solutions for people in remote areas lacking access to healthcare and medical services. Noninvasive wearable biosensors integrate innovations into wearable electronics with compact biosensing technology. They are available as small, portable devices that can be worn on the body, integrated into clothing, or mounted on handheld equipment. Overall, wearable biosensors represent a significant development in healthcare technology.

Optical biosensors are likely to record the highest CAGR in the biosensor technologies market from 2025 to 2030.

Optical biosensors are commonly used to analyze biomolecular interactions. They can determine the affinity and kinetics of various molecular interactions in real time, without requiring a molecular tag or label. Optical sensors are used for several new applications, such as drug discovery, target identification, ligand fishing, assay development, and quality control. Their advantages include high specificity, sensitivity, small size, and cost-effectiveness compared to other technologies. Moreover, with the aid of nanotechnology, optical biosensors will become more superior in sensitivity. These are among the factors contributing to the high growth of the market for optical sensors during the forecast period.

North America is expected to hold the largest share of the biosensors market in 2030.

North America held the largest share of the overall biosensors market in 2030. PoC diagnostics is the fastest-growing application for biosensors in North America. The growth is attributed to the increase in the accessible patient population. According to the American Medical Association, the number of Americans suffering from chronic diseases was about 133 million in 2025, which is expected to reach 170 million by 2030. The rise in the waiver of Clinical Laboratory Improvement Amendments (CLIA) for specific point-of-care (PoC) diagnostic devices, such as coagulation, glucose monitoring, and hematology devices, further drives the growth of the biosensors market in North America. In North America, environmental changes are monitored through organized networks. Biosensors are adopted as environmental monitoring tools to assess soil, water, and air quality. Biodefense is another application contributing to this region's increasing demand for biosensors.

Key Players

Key companies operating in the biosensors market include Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (Ireland), Bio-Rad Laboratories, Inc. (US), DuPont (US), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (US), Masimo (US), Nova Biomedical (US), Universal Biosensors (Australia), ACON Laboratories (US).

Don’t miss out on business opportunities in Biosensors Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/